Purpose. A case of a patient who developed thrombotic thrombocytopenic purpura (TTP) after consuming a weight-loss product containing green tea is reported. Summary. A 38-year-old, 68-kg Caucasian ...

The article also provides an analysis of TTP incidence in the Nanjing area ... Despite negative SARS-CoV-2 PCR test results, the patient was treated with dexamethasone, intravenous immunoglobulin ...

1 Now known as thrombotic thrombocytopenic purpura (TTP), this rare disease features a dramatic reduction in platelets caused by clots that are formed in blood vessels. This can have potentially ...

Wu’s centre is a major player in China for running a global trial of TTP patients, led by Takeda, a global biopharmaceutical company. Takeda’s drug candidate replaces ADAMTS13, and aims to ...

Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regulatory ...